Hemophagocytic Lymphohistiocytosis Market

Hemophagocytic lymphohistiocytosis is a life-threatening disorder characterized by unbridled activation of cytotoxic T lymphocytes, natural killer (NK) cells, and macrophages resulting in hypercytokinemia and immune-mediated injury of multiple organ systems.

Hemophagocytic Lymphohistiocytosis Market Key Facts

As per the John Hopkins Medicine, there are 2 types of HLH: familial and acquired. Familial HLH accounts for about 25% of cases and families pass down the condition.
In a study conducted in Japan by Iishi et al., the male/female ratio was 0.94. Also, the incidence of FHL was estimated as 1 in 50,000 to 300,000 live births in Japan.
According to the NORD, in adults, men are slightly more affected than females.

DelveInsight's "Hemophagocytic Lymphohistiocytosis Market Insights, Epidemiology, and Market Forecast 2030" report delivers an in-depth understanding of the Hemophagocytic Lymphohistiocytosis market Size and Share, historical and forecasted epidemiology analysis as well as the Hemophagocytic Lymphohistiocytosis market trends in the seven major markets (i.e. the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan).

For more information on Hemophagocytic Lymphohistiocytosis market, visit: https://www.delveinsight.com/report-store/hemophagocytic-lymphohistiocytosis-market